Discontinuation of anti-PD-1 monotherapy in advanced melanoma-Outcomes of daily clinical practice

MLA

Zeijl, M. C. T.van, et al. “Discontinuation of Anti-PD-1 Monotherapy in Advanced Melanoma-Outcomes of Daily Clinical Practice.” International Journal of Cancer, 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1366943459&authtype=sso&custid=ns315887.

APA

Zeijl, M. C. T. van, Eertwegh, A. J. van den, Wouters, M., Wreede, L. C. de, Aarts, M. J., Berkmortel, F. van den, Groot, J. B. de, Hospers, G. A., Kapiteijn, E., Piersma, D., Rijn, R. S. van, Suijkerbuijk, K. P., Tije, A. J. T., Veldt, A. A. M. van der, Vreugdenhil, G., Hoeven, J. J. M. van der, & Haanen, J. (2022). Discontinuation of anti-PD-1 monotherapy in advanced melanoma-Outcomes of daily clinical practice. International Journal of Cancer.

Chicago

Zeijl, M.C.T. van, A.J. van den Eertwegh, M. Wouters, L.C. de Wreede, M.J. Aarts, F. van den Berkmortel, J.B. de Groot, et al. 2022. “Discontinuation of Anti-PD-1 Monotherapy in Advanced Melanoma-Outcomes of Daily Clinical Practice.” International Journal of Cancer. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1366943459&authtype=sso&custid=ns315887.